Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial

Overview of attention for article published in Respiratory Research, June 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,664 followers.

New article: Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial https://t.co/HybUtnUTWR

Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial https://t.co/yfiMrlmx7W

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.